Profitability
This table compares Precision Optics and NeurAxis’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Precision Optics | -20.01% | -35.51% | -21.67% |
| NeurAxis | -492.76% | N/A | -641.25% |
Institutional and Insider Ownership
13.7% of Precision Optics shares are held by institutional investors. Comparatively, 11.8% of NeurAxis shares are held by institutional investors. 16.3% of Precision Optics shares are held by company insiders. Comparatively, 15.2% of NeurAxis shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Earnings & Valuation
This table compares Precision Optics and NeurAxis”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Precision Optics | $18.98 million | 1.61 | -$2.95 million | ($0.62) | -7.74 |
| NeurAxis | $2.46 million | 7.08 | -$14.63 million | ($1.84) | -1.35 |
Risk & Volatility
Precision Optics has a beta of 0.27, meaning that its share price is 73% less volatile than the S&P 500. Comparatively, NeurAxis has a beta of 4.2, meaning that its share price is 320% more volatile than the S&P 500.
Summary
Precision Optics beats NeurAxis on 7 of the 11 factors compared between the two stocks.
About Precision Optics
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.
About NeurAxis
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
Receive News & Ratings for Precision Optics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precision Optics and related companies with MarketBeat.com's FREE daily email newsletter.
